“It is health that is real wealth”

At FarmaSyn S.A. we discovered long ago that, in life, real wealth is health – the most valuable gift we have been given! For over twenty years we have dedicated ourselves with enthusiasm and persistence to supplying high quality pharmaceutical products, endeavouring to make them accessible to all patients.

Our activities

Representation of foreign firms

Within the framework of our efforts to provide patients with value-for money, quality pharmaceutical products we are sole representatives for many well-known medicines from companies abroad.

Developing our own products

The company’s product portfolio is completed with medicines of equivalent quality that we ourselves have developed in collaboration with manufacturers in Greece and elsewhere in Europe, thus ensuring the safety and value of our products.

Our strategic collaboration with Sandoz, one of the largest generic manufacturers in the world, has greatly expanded the range of therapeutic categories we are able to offer and has allowed us to complete our range of pharmaceutical products.

23

Years in Greek Market

100

%

Greek Company

616

th

Amongst largest Greek companies

7.800.000

Patients have used our products (IMS Data)

News - Announcements

arthritis

24

Aug2017
Just 45 minutes a week of moderate to vigorous exercise may help improve or maintain a high level of function for people with osteo arthritis (OA), according to study published online recently in Arthritis Care & Research. Current guidelines from the Department of Health and Human Services for ... Read More
24 August 2017Mentory

28

Jun
New research into the biomarkers that predict the onset of Alzheimer’s suggests that more than twice as many people are in some stage of the disease than the official numbers indicate. Roughly 5.4 million people in the US are estimated to have Alzheimer’s, but that number is likely closer ...

23

Jun
Pharmaceutical grade chondroitin sulfate has proved efficacy in the treatment and delay of knee osteoarthritis, according to the latest published evidence on osteoarthritis treatment has been presented at a symposium organized by Bioiberica and IBSA at the ...

20

Feb
For years doctors have been uncertain what the optimal goal should be for patients with high blood pressure. The aim of course is to bring it down, but how far and how aggressively remained a mystery. Researchers report that lowering blood pressure to 120 — instead of the current guideline of ...

Products

Communication

Health Professionals

Patients